Like what we do? Donate to support Word on the Tree

Donate

  • June 7, 2017

    First state to legalize weed has lowest unemployment rate in the country

    Three years after legalizing adult-use sales, Colorado's jobless rate is at 2.3 percent

    According to governor John Hickenlooper, multiple factors have contributed to Colorado’s job growth, including the state’s business-friendly policies. One of the main factors in Colorado’s successful economy is undeniably the cannabis industry.

  • October 31, 2017

    Marijuana legalization 'will lead to more death' says Christie

    What Trump's opioid commission thinks about cannabis, how police use marijuana to smear victims of violence, and more in today's newsletter.

    Chair of White House opioid commission spouts reefer madness, how police use drug convictions to smear victims of violence, and a look at whether public banks could fix the industry's financial woes. Plus: A California cannabis company took out ads in TSA bins that read "CANNABIS IS LEGAL."

  • August 9, 2018

    The FDA-approved CBD drug will cost $32,500 a year for epilepsy patients

    A look at Epidiolex's hefty price tag, a case in North Dakota will test CBD's legality, and more in today's newsletter.

    The FDA-approved CBD drug for epilepsy is going to cost $32,500 a year. A CBD case in North Dakota is going to test the DEA's interpretation of the law. A new bill in Congress hopes to protect federal employees from losing their jobs for using medical marijuana. Also: A new mother had her child kept away from her for five days because of a poppy seed bagel.

  • May 26, 2017

    'There’s been too much legalization talk,' says Sessions

    The attorney general doubles down on drugs-violence link, the DEA chief says 'marijuana is not medicine,' and more in today's newsletter.

    In a speech he gave in Memphis, Tenn. he argued that a recent "surge" in violent crime was tied to a decrease in drug prosecutions by the Obama administration.

  • March 24, 2017

    The DEA awards Schedule II status to synthetic THC drug

    Pharma company gets approval for synthetic THC formulation, one man is fighting his life sentence for a marijuana offense, and more in today's newsletter.

    A pharmaceutical company's synthetic THC solution Syndros has gotten the go-ahead for Schedule II status. It is a liquid formulation of Marinol (synthetic THC in capsule form), which is currently a Schedule III substance.

  • February 27, 2017

    Sessions inadvertently makes an argument for cannabis legalization

    The attorney general said he is 'not a fan' of marijuana and is reviewing the Cole Memo.

    In his first briefing with reporters as attorney general, Jeff Sessions said he was looking into the Cole Memo. "I am definitely not a fan of expanded use of marijuana," he said.

  • March 1, 2017

    Republican congressman introduces bill to legalize marijuana

    Tom Garrett revives Bernie Sanders' legalization bill, Colorado's AG wants Sessions to visit the state, and more in today's newsletter.

    In president Donald Trump's joint address to Congress, he pledged to build a wall that will "slow down and ultimately stop" the "terrible drug epidemic." But evidence shows that a wall would do little to stop drug trafficking across the border.